Individual results vary based on health factors
In one study, 12-week treatment with insulin glargine vs liraglutide (mean dose = 1.3 mg/day) showed similar glycemic control and decrease of hepatic fat burden, although a reduction in BMI was only observed in the liraglutide-treated patients (68)
It takes only minutes to prepare and its GLP-1 friendly
Unlike older growth hormone therapies, it works with your bodys natural rhythm and has fewer side effects
Foster long-term lifestyle changes that enhance the benefits of GLP-1 medications
While peptide-based GLP-1 receptor agonists such as Exenatide, Liraglutide, Dulaglutide, and Semaglutide have demonstrated strong efficacy, there remains significant interest in developing next-generation therapies